Since alterations in the TP53 tumor suppressor gene occur in about 50% of NSCLC cases [23], we investigated the contribution of functional p53 signaling to the effects of BOK in lung adenocarcinoma by crossing the KrasG12DBok−/− mice in a Tp53fl/fl background. This evidence concerns the gene BOK and non-small cell lung carcinoma.